TCIM
DGX icon

TIAA CREF Investment Management’s Quest Diagnostics DGX Stock Holding History

TIAA CREF Investment Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$27.8M Sell
308,616
-49,522
-14% -$4.29M 0.02% 585
2018
Q4 		$29.8M Buy
358,138
+10,355
+3% +$971K 0.02% 526
2018
Q3 		$37.5M Buy
347,783
+5,129
+1% +$563K 0.02% 523
2018
Q2 		$37.7M Sell
342,654
-43,311
-11% -$4.51M 0.03% 519
2018
Q1 		$38.7M Sell
385,965
-51,825
-12% -$5.31M 0.03% 520
2017
Q4 		$43.1M Sell
437,790
-97,989
-18% -$9.29M 0.03% 491
2017
Q3 		$50.2M Sell
535,779
-168,167
-24% -$17.9M 0.03% 448
2017
Q2 		$78.3M Buy
703,946
+30,633
+5% +$3.24M 0.05% 343
2017
Q1 		$66.1M Buy
673,313
+100,404
+18% +$9.57M 0.05% 381
2016
Q4 		$52.6M Sell
572,909
-33,032
-5% -$2.85M 0.04% 416
2016
Q3 		$51.3K Buy
605,941
+47,782
+9% +$4.01M 0.03% 439
2016
Q2 		$45.4M Buy
558,159
+159,572
+40% +$12.2M 0.03% 449
2016
Q1 		$28.5M Sell
398,587
-54,477
-12% -$3.65M 0.02% 621
2015
Q4 		$32.2M Buy
453,064
+112,754
+33% +$7.58M 0.02% 603
2015
Q3 		$20.9M Buy
340,310
+1,080
+0.3% +$75.5K 0.02% 726
2015
Q2 		$24.6M Sell
339,230
-194,300
-36% -$14.3M 0.02% 719
2015
Q1 		$41M Buy
533,530
+80,760
+18% +$5.78M 0.03% 537
2014
Q4 		$30.4M Buy
452,770
+50,247
+12% +$3.17M 0.02% 613
2014
Q3 		$24.4M Sell
402,523
-12,187
-3% -$751K 0.02% 703
2014
Q2 		$24.3M Sell
414,710
-7,066
-2% -$414K 0.02% 721
2014
Q1 		$24.4M Sell
421,776
-8,486
-2% -$455K 0.02% 713
2013
Q4 		$23M Sell
430,262
-123,812
-22% -$7.34M 0.02% 733
2013
Q3 		$34.2M Buy
554,074
+61,750
+13% +$3.7M 0.03% 568
2013
Q2 		$29.9M Buy
+492,324
New +$29.3M 0.02% 589

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TIAA CREF Investment Management's DGX Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Quest Diagnostics (DGX) stake by 14% in Q1 2019, selling an estimated $4.29M and leaving 308,616 shares worth $27.8M. The position accounts for 0.02% of the portfolio, ranked #585.

TIAA CREF Investment Management first reported a position in DGX in Q2 2013 and has held it in 24 quarters since. The position peaked at $78.3M in Q2 2017. 656 funds tracked by Wall St. Rank hold DGX as of Q1 2019.

  • TIAA CREF Investment Management held 308,616 shares of Quest Diagnostics worth $27.8M as of Q1 2019.
  • TIAA CREF Investment Management sold 49,522 Quest Diagnostics shares in Q1 2019, an estimated $4.29M.
  • Quest Diagnostics made up 0.02% of TIAA CREF Investment Management's portfolio in Q1 2019, its #585 holding.
  • TIAA CREF Investment Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Quest Diagnostics position peaked at $78.3M in Q2 2017.
  • 656 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.